Please enable JavaScript to continue using this application.

Compare $ATRA vs $BMEA | Chartloom

Compare

$ATRA vs $BMEA

Atara Biotherapeutics Inc · Biomea Fusion Inc

ATRA

Atara Biotherapeutics Inc

BMEA

Biomea Fusion Inc

Compare $ATRA vs $BMEA

Comparing Atara Biotherapeutics Inc and Biomea Fusion Inc

ATRAAtara Biotherapeutics Inc

BMEABiomea Fusion Inc

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

BMEABiomea Fusion Inc

Market cap

$103M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.0%

52W performance

-15.5%

FCF yield

-46.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

BMEA

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

BMEA

Biomea Fusion Inc

Market Cap

ATRA$85M

BMEA$103M

Enterprise Value

ATRA$124M

BMEA$68M

Price

ATRA$9.48

BMEA$1.42

P/E Ratio

ATRAN/A

BMEAN/A

P/S Ratio

ATRA13.79x

BMEA0.00x

EV/Sales

ATRA19.98x

BMEA0.00x

EV/EBITDA

ATRA3.51x

BMEA0.00x

P/B Ratio

ATRA12.86x

BMEA7.58x

P/FCF Ratio

ATRAN/A

BMEAN/A

EV/FCF

ATRA-5.65x

BMEA-1.44x

PEG Ratio

ATRAN/A

BMEAN/A

Forward P/E (NTM)

ATRA14.78x

BMEAN/A

Forward P/S (NTM)

ATRA2.47x

BMEAN/A

Revenue (TTM)

ATRA$6M

BMEA$0

Revenue Growth (YoY)

ATRA-96.7%

BMEAN/A

Forward Rev Growth

ATRA1983.2%

BMEA-19.3%

Gross Margin (TTM)

ATRA91.4%

BMEA0.0%

Operating Margin (TTM)

ATRA0.0%

BMEA0.0%

EBITDA Margin (TTM)

ATRA-194.7%

BMEA0.0%

Net Margin (TTM)

ATRA-269.4%

BMEA0.0%

FCF Margin (TTM)

ATRA-353.5%

BMEAN/A

Net Income (TTM)

ATRA$-17M

BMEA$-33M

FCF (TTM)

ATRA$-22M

BMEA$-47M

EPS (TTM)

ATRA-$1.11

BMEA-$0.45

ROE (TTM)

ATRA-31542.0%

BMEA-17119.0%

ROA (TTM)

ATRA-7301.0%

BMEA-6606.0%

ROIC (TTM)

ATRA-30684.0%

BMEA-17119.0%

Cash

ATRA$3M

BMEA$35M

Debt

ATRA$42M

BMEA$0

Net Cash/Debt

ATRA$-38M

BMEA$35M

Current Ratio (TTM)

ATRA1.98x

BMEA3.48x

Quick Ratio (TTM)

ATRA1.98x

BMEA3.36x

Debt/Equity (TTM)

ATRA0.12x

BMEA0.00x

Debt/Assets (TTM)

ATRA0.0%

BMEA0.0%

Interest Coverage (TTM)

ATRAN/A

BMEAN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

BMEA0.00x

Beta

ATRA0.31

BMEA-0.24

52W Performance

ATRA-40.2%

BMEA-15.5%

YTD Performance

ATRA-46.7%

BMEA6.0%

% from 52W High

ATRA-50.5%

BMEA-36.5%

% from 52W Low

ATRA141.8%

BMEA62.9%

Asset Turnover (TTM)

ATRA0.27x

BMEA0.00x

FCF Yield (TTM)

ATRA-25.6%

BMEA-46.0%

Earnings Yield (TTM)

ATRA-19.5%

BMEA-31.7%

Dividend Yield (TTM)

ATRAN/A

BMEAN/A

Rule of 40

ATRA-450.2

BMEA0.0

EV/GP/RG

ATRA0.05

BMEAN/A

Ticker research

View ATRA research View BMEA research

Metric	ATRA Atara Biotherapeutics Inc	BMEA Biomea Fusion Inc
Market & Valuation
Market Cap	$85M	$103M
Enterprise Value	$124M	$68M
Price	$9.48	$1.42
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	0.00x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	7.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	-19.3%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-33M
FCF (TTM)	$-22M	$-47M
EPS (TTM)	-$1.11	-$0.45
ROE (TTM)	-31542.0%	-17119.0%
ROA (TTM)	-7301.0%	-6606.0%
ROIC (TTM)	-30684.0%	-17119.0%
Financial Health
Cash	$3M	$35M
Debt	$42M	$0
Net Cash/Debt	$-38M	$35M
Current Ratio (TTM)	1.98x	3.48x
Quick Ratio (TTM)	1.98x	3.36x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-0.24
52W Performance	-40.2%	-15.5%
YTD Performance	-46.7%	6.0%
% from 52W High	-50.5%	-36.5%
% from 52W Low	141.8%	62.9%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-25.6%	-46.0%
Earnings Yield (TTM)	-19.5%	-31.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View BMEA research

Valuation

P/S Ratio

BMEA

0.00x

ATRA

13.79x

EV/FCF

ATRA

-5.65x

BMEA

-1.44x

Growth & revenue

Revenue Growth TTM

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

BMEA

-19.3%

Profitability & performance

Gross Margin

ATRA

91.4%

BMEA

0.0%

ROE

BMEA

-17119.0%

ATRA

-31542.0%

FCF Yield %

ATRA

-25.6%

BMEA

-46.0%

52-Week Performance

BMEA

-15.5%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

BMEA

Biomea Fusion Inc

Market Cap

ATRA$85M

BMEA$103M

Enterprise Value

ATRA$124M

BMEA$68M

Price

ATRA$9.48

BMEA$1.42

P/E Ratio

ATRAN/A

BMEAN/A

P/S Ratio

ATRA13.79x

BMEA0.00x

EV/Sales

ATRA19.98x

BMEA0.00x

EV/EBITDA

ATRA3.51x

BMEA0.00x

P/B Ratio

ATRA12.86x

BMEA7.58x

P/FCF Ratio

ATRAN/A

BMEAN/A

EV/FCF

ATRA-5.65x

BMEA-1.44x

PEG Ratio

ATRAN/A

BMEAN/A

Forward P/E (NTM)

ATRA14.78x

BMEAN/A

Forward P/S (NTM)

ATRA2.47x

BMEAN/A

Revenue (TTM)

ATRA$6M

BMEA$0

Revenue Growth (YoY)

ATRA-96.7%

BMEAN/A

Forward Rev Growth

ATRA1983.2%

BMEA-19.3%

Gross Margin (TTM)

ATRA91.4%

BMEA0.0%

Operating Margin (TTM)

ATRA0.0%

BMEA0.0%

EBITDA Margin (TTM)

ATRA-194.7%

BMEA0.0%

Net Margin (TTM)

ATRA-269.4%

BMEA0.0%

FCF Margin (TTM)

ATRA-353.5%

BMEAN/A

Net Income (TTM)

ATRA$-17M

BMEA$-33M

FCF (TTM)

ATRA$-22M

BMEA$-47M

EPS (TTM)

ATRA-$1.11

BMEA-$0.45

ROE (TTM)

ATRA-31542.0%

BMEA-17119.0%

ROA (TTM)

ATRA-7301.0%

BMEA-6606.0%

ROIC (TTM)

ATRA-30684.0%

BMEA-17119.0%

Cash

ATRA$3M

BMEA$35M

Debt

ATRA$42M

BMEA$0

Net Cash/Debt

ATRA$-38M

BMEA$35M

Current Ratio (TTM)

ATRA1.98x

BMEA3.48x

Quick Ratio (TTM)

ATRA1.98x

BMEA3.36x

Debt/Equity (TTM)

ATRA0.12x

BMEA0.00x

Debt/Assets (TTM)

ATRA0.0%

BMEA0.0%

Interest Coverage (TTM)

ATRAN/A

BMEAN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

BMEA0.00x

Beta

ATRA0.31

BMEA-0.24

52W Performance

ATRA-40.2%

BMEA-15.5%

YTD Performance

ATRA-46.7%

BMEA6.0%

% from 52W High

ATRA-50.5%

BMEA-36.5%

% from 52W Low

ATRA141.8%

BMEA62.9%

Asset Turnover (TTM)

ATRA0.27x

BMEA0.00x

FCF Yield (TTM)

ATRA-25.6%

BMEA-46.0%

Earnings Yield (TTM)

ATRA-19.5%

BMEA-31.7%

Dividend Yield (TTM)

ATRAN/A

BMEAN/A

Rule of 40

ATRA-450.2

BMEA0.0

EV/GP/RG

ATRA0.05

BMEAN/A

Ticker research

View ATRA research View BMEA research

Metric	ATRA Atara Biotherapeutics Inc	BMEA Biomea Fusion Inc
Market & Valuation
Market Cap	$85M	$103M
Enterprise Value	$124M	$68M
Price	$9.48	$1.42
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	0.00x
EV/Sales	19.98x	0.00x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	7.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	-19.3%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-33M
FCF (TTM)	$-22M	$-47M
EPS (TTM)	-$1.11	-$0.45
ROE (TTM)	-31542.0%	-17119.0%
ROA (TTM)	-7301.0%	-6606.0%
ROIC (TTM)	-30684.0%	-17119.0%
Financial Health
Cash	$3M	$35M
Debt	$42M	$0
Net Cash/Debt	$-38M	$35M
Current Ratio (TTM)	1.98x	3.48x
Quick Ratio (TTM)	1.98x	3.36x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-0.24
52W Performance	-40.2%	-15.5%
YTD Performance	-46.7%	6.0%
% from 52W High	-50.5%	-36.5%
% from 52W Low	141.8%	62.9%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-25.6%	-46.0%
Earnings Yield (TTM)	-19.5%	-31.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View BMEA research